[Discontinuation of antidepressant serotonergic antidepressant]

Ugeskr Laeger. 2010 Jan 25;172(4):296-8.
[Article in Danish]

Abstract

A middle-aged female patient who had been automedicating with two different selective serotonin reuptake inhibitors and a selective serotonin-noradrenalin-reuptake inhibitor (SNRI) was non-intentionally exposed to an abrupt dose reduction upon admittance which caused her to develop the SNRI discontinuation syndrome (DS) ten days later. Discontinuation symptoms are described for almost all major groups of anti-depressants. The absence of typical withdrawal hallmarks distinguishes DS from withdrawal conditions. Furthermore, it is important to distinguish DS from relapse of depression.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antidepressive Agents, Second-Generation / administration & dosage
  • Antidepressive Agents, Second-Generation / adverse effects*
  • Citalopram / administration & dosage
  • Citalopram / adverse effects
  • Cyclohexanols / administration & dosage
  • Cyclohexanols / adverse effects
  • Depressive Disorder / diagnosis
  • Depressive Disorder / drug therapy
  • Diagnosis, Differential
  • Female
  • Humans
  • Middle Aged
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Substance Withdrawal Syndrome / diagnosis
  • Substance Withdrawal Syndrome / etiology*
  • Venlafaxine Hydrochloride

Substances

  • Antidepressive Agents, Second-Generation
  • Cyclohexanols
  • Serotonin Uptake Inhibitors
  • Citalopram
  • Venlafaxine Hydrochloride